Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MADe IT: Molecular Analyses Directed Individualized Therapy in NSCLC
NCT00215930Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Feb 2004
- Primary completion
- Oct 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, docetaxel, gemcitabine, carboplatin in non-small cell lung cancer (NSCLC), sponsored by Moffitt Cancer Center. Started Feb 2004; status: completed.
02
Drugs
vinorelbinedocetaxelgemcitabinecarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00215930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215930.